[HTML][HTML] Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular …

S Roy, C Coldren, A Karunamurthy, NS Kip… - The Journal of Molecular …, 2018 - Elsevier
Bioinformatics pipelines are an integral component of next-generation sequencing (NGS).
Processing raw sequence data to detect genomic alterations has significant impact on …

[HTML][HTML] International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of …

WD Travis, E Brambilla, M Noguchi… - Journal of thoracic …, 2011 - Elsevier
Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

[HTML][HTML] Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American …

NI Lindeman, PT Cagle, MB Beasley, DA Chitale… - Journal of Thoracic …, 2013 - Elsevier
Objective To establish evidence-based recommendations for the molecular analysis of lung
cancers that are that are required to guide EGFR-and ALK-directed therapies, addressing …

New pathologic classification of lung cancer: relevance for clinical practice and clinical trials

WD Travis, E Brambilla, GJ Riely - Journal of clinical oncology, 2013 - ascopubs.org
We summarize significant changes in pathologic classification of lung cancer resulting from
the 2011 International Association for the Study of Lung Cancer/American Thoracic …

Rethink of EGFR in cancer with its kinase independent function on board

R Thomas, Z Weihua - Frontiers in oncology, 2019 - frontiersin.org
The epidermal growth factor receptor (EGFR) is one of most potent oncogenes that are
commonly altered in cancers. As a receptor tyrosine kinase, EGFR's kinase activity has been …

EGFR mutations and lung cancer

G da Cunha Santos, FA Shepherd… - Annual Review of …, 2011 - annualreviews.org
Epidermal growth factor receptor (EGFR) is a transmembrane protein with cytoplasmic
kinase activity that transduces important growth factor signaling from the extracellular milieu …

Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society …

WD Travis, E Brambilla, M Noguchi… - … of Pathology and …, 2013 - meridian.allenpress.com
The new International Association for the Study of Lung Cancer/American Thoracic
Society/European Respiratory Society lung adenocarcinoma classification provides, for the …

[HTML][HTML] Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update

G Bethune, D Bethune, N Ridgway… - Journal of thoracic …, 2010 - ncbi.nlm.nih.gov
Epidermal growth factor receptor is a trans-membrane glycoprotein with an extracellular
epidermal growth factor binding domain and an intracellular tyrosine kinase domain that …

An overview of EGFR mechanisms and their implications in targeted therapies for glioblastoma

SMB Rodriguez, A Kamel, GV Ciubotaru… - International Journal of …, 2023 - mdpi.com
Despite all of the progress in understanding its molecular biology and pathogenesis,
glioblastoma (GBM) is one of the most aggressive types of cancers, and without an efficient …

[HTML][HTML] Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer

KM Kerr, L Bubendorf, MJ Edelman, A Marchetti… - Annals of …, 2014 - Elsevier
To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The Second …